| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | NAPSIN A Blocking Peptide is synthetically produced from the 250-300 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | NAPSA |
| Gene ID: | 9476 |
| Uniprot ID: | NAPSA_HUMAN |
| Immunogen Region: | 250-300 |
| Immunogen: | Synthetic peptide taken within amino acid region 250-300 on human Napsin A protein. |
| Tissue Specificity | Expressed predominantly in adult lung (type II pneumocytes) and kidney and in fetal lung. Low levels in adult spleen and very low levels in peripheral blood leukocytes. |
| Function | May be involved in processing of pneumocyte surfactant precursors. |
| Peptide Name | Napsin-AAspartyl Protease 4Asp4Asp 4Napsin-1Ta01/Ta02 |
| Database Links | Reactome: R-HSA-5683826 |
| Cellular Localisation | Secreted |
| Alternative Peptide Names | Napsin-A proteinAspartyl Protease 4 proteinAsp4 proteinAsp 4 proteinNapsin-1 proteinTa01/Ta02 proteinNAPSA proteinNAP1 proteinNAPA protein |
Information sourced from Uniprot.org